Neonatal Diseases
Conditions
Interventions
Baseline data collection
Sponsors
Bill and Melinda Gates Foundation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Neonates admitted to the KNH newborn unit during the study period who are born less than 34 weeks gestational age or with a birthweight less than 1500 grams where the gestational age is unknown and who are estimated to have a gestational age less than 34 weeks by New Ballard Scoring for gestational assessment as per current practice at KNH; Neonates on either aminophylline or caffeine citrate based on existing clinical criteria or clinical events;
Exclusion criteria
Exclusion criteria: Unwillingness or inability of the neonate’s caregiver to provide informed consent for data collection and use. Neonates who would be unlikely to be transferred out of the newborn unit and not accessible for followup
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A context-appropriate apnea of prematurity clinical care bundle which is acceptable to stakeholders | — |
Secondary
| Measure | Time frame |
|---|---|
| An assessment of feasibility, usability, and acceptability of the apnea of prematurity clinical care bundle that includes monitoring of at-risk neonates and managing apnea of prematurity with caffeine citrate by healthcare administrators, healthcare providers, and caregivers.;Identified barriers to and facilitators for effective implementation of the apnea of prematurity clinical care bundle. | — |
Countries
Kenya
Contacts
Public ContactDorothy Chomba
Research Coordinator
Outcome results
None listed